Stockscreener 앱 받기
18.78
0.00%
0.01
시간 외 거래:
18.80
0.02
+0.11%
전일 마감가:
$18.77
열려 있는:
$18.92
하루 거래량:
155.17K
Relative Volume:
0.50
시가총액:
$712.56M
수익:
$89.06M
순이익/손실:
$-53.41M
주가수익비율:
-12.85
EPS:
-1.4612
순현금흐름:
$-42.48M
1주 성능:
+10.67%
1개월 성능:
-11.38%
6개월 성능:
+11.00%
1년 성능:
+13.21%
1일 변동 폭
$18.60
$19.13
1주일 범위
$16.96
$19.20
52주 변동 폭
$10.85
$24.33
Ceribell Inc Stock (CBLL) Company Profile
명칭
Ceribell Inc
전화
(800) 436-0826
주소
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
18.78 | 712.18M | 89.06M | -53.41M | -42.48M | -1.4612 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2025-06-24 | 개시 | BTIG Research | Buy |
| 2025-04-04 | 개시 | Ladenburg Thalmann | Buy |
| 2024-11-05 | 개시 | BofA Securities | Buy |
| 2024-11-05 | 개시 | Canaccord Genuity | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Ceribell Inc 주식(CBLL)의 최신 뉴스
Ceribell CEO to present at William Blair Growth Stock Conference on June 3, 2026 - Pluang
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference - GlobeNewswire
Earnings call transcript: Ceribell Inc. Q1 2026 misses EPS, revenue up - Investing.com Nigeria
Bank of America Securities Remains a Buy on Ceribell, Inc. (CBLL) - The Globe and Mail
Canaccord Genuity maintains Ceribell (CBLL) buy recommendation - MSN
Ceribell anticipates $112M-$116M 2026 revenue while targeting delirium NTAP of up to $2,171 per patient - MSN
CBLL Stock Price, Quote & Chart | CERIBELL INC (NASDAQ:CBLL) - ChartMill
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records - Yahoo Finance
Ladenburg Thalmann Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Middle East Tensions Threaten Ceribell’s Supply Chain, Shipping Routes, and Margins - TipRanks
Ceribell’s Earnings Call Signals Growth Over Profits - The Globe and Mail
TD Cowen Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $29 - Moomoo
A Quick Look at Today's Ratings for Ceribell(CBLL.US), With a Forecast Between $25 to $29 - Moomoo
Canaccord lowers Ceribell stock price target on valuation compression By Investing.com - Investing.com Australia
Canaccord lowers Ceribell stock price target on valuation compression - Investing.com
Ceribell: Buy Rating Reiterated on Strong Q1 Momentum and Expanded TAM, $28 Price Target Maintained - TipRanks
Ceribell Reports First Quarter 2026 Financial Results - The Manila Times
Ceribell, Inc. (CBLL) reports Q1 loss, beats revenue estimates - MSN
CeriBell Q1 Earnings Call Highlights - inkl
CeriBell (CBLL) Q1 2026 Earnings Transcript - AOL.com
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
CeriBell Q1 Loss Widens, Revenue Rises; Lifts Full-Year Revenue Guidance - Moomoo
Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised - ChartMill
CERIBELL ($CBLL) Releases Q1 2026 Earnings - Quiver Quantitative
Ceribell beats Q1 revenue estimates; lifts 2026 guidance - TradingView
(CBLL) CeriBell Now Expects 2026 Revenue Range $112M-$116M, vs. FactSet Est of $113.1M - marketscreener.com
Earnings Flash (CBLL) CeriBell Posts Q1 Per Share Loss $0.52, vs. FactSet Est of Loss $0.39 - marketscreener.com
Earnings Flash (CBLL) Ceribell, Inc. Reports Q1 Revenue $26.5M, vs. FactSet Est of $26.1M - marketscreener.com
Ceribell, Inc. Raises Revenue Guidance for the Full Year 2026 - marketscreener.com
CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ... By GuruFocus - Investing.com Canada
Number of shareholders of CeriBell, Inc. – NASDAQ:CBLL - TradingView
[144] Ceribell, Inc. SEC Filing - Stock Titan
Ceribell CEO Chao Xingjuan sells $783,973 in stock By Investing.com - Investing.com South Africa
Ceribell CEO Chao Xingjuan sells $783,973 in stock - Investing.com India
Ceribell (NASDAQ: CBLL) CEO sells 39,000 shares after options exercise - Stock Titan
FMR LLC holds 4.85M CERIBELL shares (CBLL) — Amendment No.3 - Stock Titan
Earnings Preview: Ceribell to Report Financial Results Post-market on May 11 - Moomoo
Insider sells 78,000 CBLL shares and 2,084 more (CBLL) - Stock Titan
Ceribell CTO Raymond Woo sells $226,928 of CBLL common stock - Investing.com India
Ceribell CTO Raymond Woo sells $226,928 of CBLL common stock By Investing.com - Investing.com South Africa
Ceribell (NASDAQ: CBLL) CTO sells shares under 10b5-1 trading plan - Stock Titan
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference - 富途牛牛
CBLL (CBLL) Form 144 shows option-based sales and recent insider disposals - Stock Titan
CeriBell, Inc. (NASDAQ:CBLL) Sees Significant Decrease in Short Interest - MarketBeat
Ceribell Inc (CBLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.35%
2.06%
자본화:
|
볼륨(24시간):